chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had J&J COVID-19 vaccine 4/2- headache, fevers chills for about 48 hours        headaches and waves of nausea continued        neck and shoulder blades achey        Feels like pressure on both sides of her head       4/9 trouble breathing        4/11- frontal headache, nausea got worse, vomited 2 nights in a row due to coughing
Radiates down to my foot; Aching pain in my right leg; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Sep2021 at 16:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient previously took morphine (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. On 18Sep2021 at 13:00, two weeks after the second dose the patient experienced aching pain in her right leg that radiated down to her foot. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On 09Sep2021, the patient underwent COVID-19 test via nasal swab and the result was negative. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event aching pain in right leg that radiated down to her foot was not resolved at the time of this report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Client's mother contacted me and stated that the child had been screaming and vomiting since they had gotten home from getting the vaccinations, approximately an hour.  Client stated that child was also drooling.  Mother was concerned whether it was the vaccination or not.  Instructed mother to take child to see a physician for further examination.  Mother took child to Hospital to be evaluated.  Child was not given an IV fluids in the ER.  Child was discharged and mother was to continue monitoring child, make sure he takes some fluids, but he were to continue to vomit to bring him back in for IV fluids.
"L arm red, hot, hard" per mother; afebrile. Advised to see primary care physician or go to ER. Mother added: "looks like a big red blotch" not swollen-upper arm red and hard  "not swollen".
Patient developed hives 24hr after receiving vaccine. Hives were on (L) arm, (L) side torso and (L) upper leg. Seen in ED - Treated with steroids. All hives resolved within 48 hr.
On 5/18/2021, I got the Janssen shot. I was informed about the blood clotting risk (that only applied to women) and that I shouldn't worry otherwise. I was given the shot around 2pm or so and went home. For the next few days I was extremely tired and stuck in bed, while also feeling brain fog. I was registering a fever of 100 to 101, dipping down to 99 and then 98 over the next few days. The brain fog was what really stuck out, as I questioned if I made the right choice and thought I was going to be unable to live life. As I've always been nervous and stressed all my life, this intensified during this week.
Multiple sclerosis has been exacerbated; Paralysis in her left side of the body; Weakness in her left side of the body; This spontaneous case was reported by a consumer and describes the occurrence of MULTIPLE SCLEROSIS (Multiple sclerosis has been exacerbated), HEMIPLEGIA (Paralysis in her left side of the body) and HEMIPARESIS (Weakness in her left side of the body) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032821A) for COVID-19 vaccination.     Concurrent medical conditions included Multiple sclerosis.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced MULTIPLE SCLEROSIS (Multiple sclerosis has been exacerbated) (seriousness criterion medically significant), HEMIPLEGIA (Paralysis in her left side of the body) (seriousness criterion medically significant) and HEMIPARESIS (Weakness in her left side of the body) (seriousness criterion medically significant). At the time of the report, MULTIPLE SCLEROSIS (Multiple sclerosis has been exacerbated), HEMIPLEGIA (Paralysis in her left side of the body) and HEMIPARESIS (Weakness in her left side of the body) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by the reporter. Treatment information was not provided.  The second dose was administered via the left arm on 29Sep2021, lot number 006C21A and expiry date: 30Nov2021.  Company comment: This case concerns a 49-year-old, female patient with relevant medical history of Multiple Sclerosis (MS), who experienced the unexpected events of multiple sclerosis, hemiplegia and hemiparesis. The events occurred on the same day after administration of the first dose of the Moderna COVID-19 Vaccine. The rechallenge was unknown as no information about the second dose was provided. The medical history of MS, which may cause complications including paralysis and weakness, remains a confounder. The benefit-risk relationship of the Moderna COVID-19 Vaccine is not affected by this report.   This case was linked to MOD-2021-336485 (Patient Link).; Sender's Comments: This case concerns a 49-year-old, female patient with relevant medical history of Multiple Sclerosis (MS), who experienced the unexpected events of multiple sclerosis, hemiplegia and hemiparesis. The events occurred on the same day after administration of the first dose of the Moderna COVID-19 Vaccine. The rechallenge was unknown as no information about the second dose was provided. The medical history of MS, which may cause complications including paralysis and weakness, remains a confounder. The benefit-risk relationship of the Moderna COVID-19 Vaccine is not affected by this report.
After I received the booster shot I was okay for about a week. I then woke up the morning of the 10th and I got really sick with a runny nose, sore throat, and cough. I started taking Robitussin, Nyquil, and Dayquil and some Sudafed. The cold lasted for about a few weeks and the it started getting harder to breath. On February 3rd I went to the urgent care and had some blood work done and it came back with elevated v-dimer. They then did a CT Scan to check for blood clot. The cough and runny nose is still here and I cant get rid of it. The sore throat is still there as well and it is throbbing.
Above vaccine given @ 7:15 a on 9/1/2021 it expired on 8/31/2021. Reported to Moderna awaiting further instruction.
lightheadedness, nauseaus, symptoms worsen when sitting or HOB elevated.  Pale, dizzy, hot flashes
Follow 1st injection of Pfizer on 3/12/2021 she developed difficulty swallowing while on the drive home.   She could only swallow by forcing it.  This was accompanied by a feeling of anxiety.    The sensation persisted over a few minutes, then improved.  Her throat hurt to swallow for a few hours, then symptoms resolved.   She was eval by her physician on 3/23/2021.
Arm was very painful immediately and is still tender 10 days later. The next day I had a very large angry red circular rash on my arm which is now just starting to fade. It also developed a few bumps and shed some skin. I had Shingles when I was 16 years old and have never had it again. The amount of my reaction to this vaccine has made it certain I will NOT be getting the second shot. FYI - I have never and will never get any Covid or mRNA shot either.
Patient complaining of muscle and joint soreness and pain in the arm where the vaccines were given. Visited doctor on 08/26/2014 and was told it was tendonitis from the vaccines. Patient was given prednisone and told to take naproxen.
Just had slightly sore arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Just had slightly sore arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Just had slightly sore arm). At the time of the report, PAIN IN EXTREMITY (Just had slightly sore arm) had resolved.            Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD-2022-583896 (Patient Link).
Patient was scheduled for Moderna # 2 injection at 2 pm, she came to the COVID clinic early for injection since she was in the building for another appt and received Pfizer instead of Moderna inadvertently by CMA as Pfizer was being administered in AM and Moderna in PM today.  Patient remained in clinic at least 15 minutes before leaving free of any adverse reactions.  After patient left clinic and documentation was being done it was identified that she received PFIZER COVID vaccination.  Notified and review of CDC guidelines done. VAERS report done. RN Practice Manager has reached out to the patient via phone to inform of issue and at time of documentation has not been able to make contact.
Case number PHEH2014US021383, is an initial spontaneous report from a nurse received on 23 OCT 2014. This report refers to a female patient of an unknown age. Her medical history and concomitant medications were not reported. She had been administered with FLUVIRIN 2014/2015 (batch number: 1412701) intramuscularly  twice in this flu season on 20 OCT 2014 and 23 OCT 2014. No adverse event was reported following this medication error (inappropriate schedule of vaccine administered).
Flushed face; Severe nausea; This is a spontaneous report from a contactable consumer (patient).  A 65-years-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the right arm on 11Jan2021 10:00 at single dose for COVID-19 immunisation. Medical history included hypertension and gastrooesophageal reflux disease. The patient previously took lisinopril and experienced drug hypersensitivity and anaphylactic reaction, diphenhydramine (BENADRYL) and experienced drug hypersensitivity and urticaria. Concomitant medication included propranolol hydrochloride (PROPRANOL), chlorthalidone (unknown manufacturer), rabeprazole sodium (ACIPHEX), vitamin c (unknown manufacturer). The patient experienced flushed face and severe nausea on 11Jan2021 13:00 with outcome of not recovered. It was unknown f treatment was performed. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination the patient had not been tested for COVID-19.  Information on the Batch/Lot number has been requested.
Upon getting up next day felt like I was having vertigo It became full blown on the 19th (two days later). Was unable to get out of bed that day. But got medicine to help with dizzy ness and nausea.  No fever. Just headache and dizziness
This is a spontaneous report from a contactable registered nurse via Pfizer sales representative. The nurse reported similar events for 2 patients. This is the second of two reports. A patient of unspecified age (16-17 unit not provided), ethnicity and gender received a single dose of TRUMENBA and MENVEO, both via an unspecified route of administration on an unspecified date. Relevant medical history and concomitant medications were not reported. The patient experienced dizziness on an unspecified date and he/she was put in observation for 2 or 3 minutes and the situation was resolved. The patient recovered form the event. Follow-up (17AUG02016) Follow-up attempts are completed. No further information is expected.
After few seconds of getting the vaccine, client loss consciousness on his way to observation and was held by staff. Assisted to sit on chair. No injuries noted. Client's legs elevated. Vital signs were taken. Client regained consciousness after 10 seconds and stated he is feeling better. Client stated he didnt eat breakfast before getting the vaccine. Water offered, tolerated well. Client was observed for 30 minutes. At 10:40 am, client AOX4, left the site on stable condition.
Pain at shot site/headache/joint pain/weak/stomach upset/ fever and chills from Flublok
Extreme dizziness, nausea, headache, vomiting left ear pain.  Went to 2 different urgent cares in 2 different towns. 1st one couldn't find anything just gave me a prescription for Meclizine for dizziness. Urgent care said small left ear irritation that was it.  Gave me a steroid shot another prescription of Meclizine and sent me on my way.  Nothing has changed and I can't get rid of the severe dizziness and ear ache.  I have not been sick at all with Covid-19 or anything else since Covid-19 started in March 2020.  And this has all started since I received the vaccine
This spontaneous report was received from a 55 year old female registered nurse with none pertinent medical history and none drug reactions/allergies refers to her self. It was reported that the nurse received 5 doses of MMR II over the last 20 years (doses, route and Lot numbers not reported) because the titer for rubella keeps coming up negative. The nurse received the 1st dose of "MMRII" as single antigens since it was not available as a combination MMR II, when the nurse was a baby. The second dose of MMR II was given to the nurse in 1977 after her son was born. The 3rd dose of MMR II was given to the nurse in 1982 when her daughter was born. The 4th dose of MMR II was given to the nurse in 1990 when she finished nursing school. The 5th dose of MMR II was given to the nurse on 01-OCT-2012. There was none concomitant therapies. The nurse sought unspecified medical attention and received unspecified treatment for adverse event. This is one of several reports from the same source. Additional information has been requested.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 42-year-old male patient received BNT162b2 (BNT162B2), on 24Feb2021 at 11:15 as dose 1, single (Lot number: EN6202), in right arm, on 17Mar2021 at 07:30 as dose 2, single (Lot number: EP7534), in right arm and on 12Oct2021 at 08:00 as dose 3 (booster), single (Lot number: FC3183) at the age of 41 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Diabetes type 2" (unspecified if ongoing); "sleep apnea" (unspecified if ongoing); "morbid obesity" (unspecified if ongoing). Concomitant medication(s) included: ATENOLOL; LOSARTAN; OMEPRAZOL; STEGLUJAN. The following information was reported: VACCINATION FAILURE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of vaccination failure, suspected covid-19.  Clinical course: it was reported that patient received other medication in 2 weeks. Patient received treatment for COVID 19 with anti-viral details with brand name Paxlovid which started on 27Nov2022 till 01Dec2022. No known allergies.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 17-FEB-2017, the patient was vaccinated with an expired dose of VAQTA injection, lot # L031196 with expiry date of 05-FEB-2017 (dose, route and site of administration were not reported). No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
Rash, red, trunk & neck. Prednisone Rx Developed rash 4 days ago/Itchy. No hx of new product/food ect....
4hrs p/vax pt became very pale & lethargic t100.6R, HR 200, lifeless, limp; Recovered spontaneously over 12hr period;
LITTLE SIDE EFFECTS; This spontaneous report received from a patient via social media via a company representative concerned a patient of unspecified age, sex, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. On an unspecified date, the patient previously received covid-19 vaccine ad26.cov2.s (Dose number in series: 1) (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown), dose was not reported, 1 total administered for prophylactic vaccination.  On an unspecified date, the patient experienced little side effects following vaccination with first dose of covid-19 vaccine ad26.cov2.s (Dose number in series: 1). On an unspecified date, the patient received covid-19 vaccine ad26.cov2.s (Dose number in series: 2) (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient had little side effects following vaccination with booster dose of covid-19 vaccine ad26.cov2.s (Dose number in series:2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of little side effects was not reported. This report was non-serious. This case, involving the same patient is linked to 20220210428 (Dose number in series: 1). This case, from the same reporter is linked to 20220216041 and 20220210047.  Version created to amend previously reported information on 03-FEB-2022. Upon review the following information was amended: Amendment Adverse Event (the case validity assessment was updated to valid from the previously incorrect assessment of non-valid).
Erythema  6 cm - induration 4 cm. Centered vesicle. No systemic Sx - Rx-Ice, BENADRYL 25 mg - qbº
Miscarriage First known pregnancy, no estimated date of delivery or birth weight, approx. 4 weeks pregnant
TOOK EXPIRED COURSE OF VIVOTIF; This spontaneous case (PVX2019-1518) was received from a consumer on 11-Jun-2019. It describes a female consumer who "took expired course of Vivotif", while being on oral Vivotif (one capsule every other day) (expiry date: Apr 2019) for typhoid prophylaxis.   Case report: The consumer took expired doses of Vivotif. The first dose was taken on 04-Jun-2019 and the last dose was on 10-Jun-2019.  Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took expired course of Vivotif" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took expired course of Vivotif" was considered as not applicable.
Narrative: Pt is a 86y.o. male who died on 03/01/2021 w/ h/o HTN, HLD, GERD, CAD, AFib, PUD, Anemia, COPD. Pt received Moderna Covid-19 Vaccination 2/2 on 02/13/2021. Unlikely that Moderna Covid-19 Vaccine caused/contributed to pt death.
This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's concurrent conditions, past drug reactions, allergies, and medical history were not provided. The patient's concomitant therapies included sterile diluent. On 26-OCT-2018, the patient was vaccinated with an improperly stored dose of PROQUAD reported lot number R012416, expiration date: 28-OCT-2019 (strength, dose, frequency and route of administration were not reported) for prophylaxis. The administered dose of the vaccine experienced a temperature excursion of -9 Celsius degrees to 8 Celsius degrees (-6.09 Celsius (C)) for 1 hour and 36 minutes as recorded by a data logger. The vaccines had not had any previous temperature excursions. There were no adverse effects reported. No product quality complaint was filed. Sender's Comments: US-009507513-1811USA001081.
After vaccine administration, the patient bled. Once the bleeding stopped, it was noted that there was a small lump bruise that developed under the skin.  The patient was unaware (no symptoms), but the technician vaccinator informed her of the bruise and I examined.  I recommended icing the site 15 min on, 15 min off (putting a towel between the ice and skin).  And if it gets worse or spreads to call us. She is not on any blood thinners
This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced out of specification product use, and incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the out of specification product use and incorrect product storage was not reported. This report was non-serious.
weakness; chills; shaking; vomiting; wretching; shaking with head bobbing; cytokine storm reaction; This spontaneous case was reported by a patient and describes the occurrence of ASTHENIA (weakness), CHILLS (chills), TREMOR (shaking), VOMITING (vomiting), RETCHING (wretching), HEAD TITUBATION (shaking with head bobbing) and CYTOKINE STORM (cytokine storm reaction) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in April 2020.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced ASTHENIA (weakness) (seriousness criterion hospitalization), CHILLS (chills) (seriousness criterion hospitalization), TREMOR (shaking) (seriousness criterion hospitalization), VOMITING (vomiting) (seriousness criterion hospitalization), RETCHING (wretching) (seriousness criterion hospitalization), HEAD TITUBATION (shaking with head bobbing) (seriousness criterion hospitalization) and CYTOKINE STORM (cytokine storm reaction) (seriousness criteria hospitalization and medically significant). At the time of the report, ASTHENIA (weakness), CHILLS (chills), TREMOR (shaking), VOMITING (vomiting), RETCHING (wretching), HEAD TITUBATION (shaking with head bobbing) and CYTOKINE STORM (cytokine storm reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Myalgia, Fever, Tachycardia, Chills Narrative: